Drug Companies Are Buying Ads on Shows They Know Donald Trump Watches
- PhRMA is top special-interest advertiser so far in 2017
- Trump claims industry is ‘getting away with murder’ on prices
Trump Says Drug Pricing Issue Is Very Important
This article is for subscribers only.
The top trade association for U.S. drugmakers is spending more on television advertising than any other special-interest group, part of a multi-year campaign to repair the industry’s reputation and counter President Donald Trump’s claims that it’s “getting away with murder” on pricing.
The Pharmaceutical Research and Manufacturers of America, commonly known as PhRMA, has already spent an estimated $8.6 million on broadcast television and cable ads in 2017, according to data from Kantar Media’s CMAG, which tracks issue ads.